Just wondering SHs' thoughts on the revised strategy progress? It's been almost 4 months now. since this was announced Are we still on track for a 2H CY2018 new drug application? I haven't learnt much from the company about progress, whether they have met with the US FDA or developed detailed project timelines. Maybe there will be more on this at next week's meeting. I sincerely hope so.
